LRRC4 mediates the formation of circular RNA CD44 to inhibit GBM cell proliferation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LRRC4 mediates the formation of circular RNA CD44 to inhibit GBM cell proliferation

Published:2021-12 Issue: Volume:26 Page:473-487
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Feng Jianbo,Ren Xing,Fu Haijuan,Li Di,Chen Xiguang,Zu Xuyu,Liu Qing,Wu Minghua

Funder

National Natural Science Foundation of China

Natural Science Foundation of Hunan Province

Key Research and Development Program of Jiangxi Province

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference47 articles.

1. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?;Feng;Cancer Commun. (Lond.),2019

2. Epidemiology of gliomas;Ostrom;Cancer Treat. Res.,2015

3. The treatment of gliomas in adulthood;Goldbrunner;Dtsch. Arztebl. Int.,2018

4. Cancer gene expression profiles associated with clinical outcomes to chemotherapy treatments;Borisov;BMC Med. Genomics,2020

5. Fluorescein sodium in the surgical treatment of recurrent glioblastoma multiforme;Höhne;World Neurosurg.,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways;Non-coding RNA Research;2024-12

2. Circular RNA hsa_circ_0094976 modulates GPR155 to inhibit gastric adenocarcinoma malignant characteristics by targeting miR-223–3p;Pathology - Research and Practice;2024-05

3. Non-coding RNAs (ncRNAs) and multidrug resistance in glioblastoma: Therapeutic challenges and opportunities;Pathology - Research and Practice;2024-01

4. Role of Non-Coding RNAs in TGF-β Signalling in Glioma;Brain Sciences;2023-09-27

5. The Glioblastoma CircularRNAome;International Journal of Molecular Sciences;2023-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3